LexDanaLexDanabeta
Inventor

David Bernard Smith

Inventor
San Mateo, CA, US

Overview

64→
Patents
2001–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 64 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes21%
C07HSugars18%
C07DHeterocyclic compounds14%
Y02ATechnologies for adaptation to climate change5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C07BGeneral methods of organic chemistry2%
C12NMicroorganisms or enzymes2%
C12YEnzymes2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
10,889,173Powertrain202110,793,591Substituted nucleosides, nucleotides and analogs thereof202010,780,105Substituted nucleosides, nucleotides and analogs thereof2020RE048171Substituted nucleosides, nucleotides and analogs thereof202010,702,523AZA-pyridone compounds and uses thereof202010,683,320Substituted nucleosides, nucleotides and analogs thereof202010,485,815Substituted nucleosides, nucleotides and analogs thereof201910,487,104Substituted nucleosides, nucleotides and analogs thereof201910,464,965Substituted nucleosides, nucleotides and analogs thereof201910,421,771Substituted nucleosides, nucleotides and analogs thereof201910,420,788Substituted nucleosides, nucleotides and analogs thereof201910,370,401Substituted nucleosides, nucleotides and analogs thereof201910,307,439Substituted nucleosides, nucleotides and analogs thereof201910,251,882Aza-pyridone compounds and uses thereof201910,208,045Aza-pyridone compounds and uses thereof201910,144,755Substituted nucleosides, nucleotides and analogs thereof201810,112,966Substituted nucleosides, nucleotides and analogs thereof201810,052,342Substituted nucleosides, nucleotides and analogs thereof20189,890,188'Substituted nucleosides, nucleotides and analogs thereof'20189,862,743'Substituted nucleosides, nucleotides and analogs thereof'20189,758,544'Substituted nucleosides, nucleotides and analogs thereof'20179,603,864'Substituted nucleosides, nucleotides and analogs thereof'20179,603,863'Substituted nucleosides, nucleotides and analogs thereof'20179,598,457'Substituted nucleosides, nucleotides and analogs thereof'20179,441,007'Substituted nucleosides, nucleotides and analogs thereof'20169,365,605'Cyclic nucleotide analogs'20169,346,848'Azido nucleosides and nucleotide analogs'20169,328,119'AZA-pyridone compounds and uses thereof'20169,278,990'Substituted nucleotide analogs'20169,249,174'Substituted nucleosides, nucleotides and analogs thereof'20169,243,022'Substituted nucleosides, nucleotides and analogs thereof'20169,073,960'Substituted nucleosides, nucleotides and analogs thereof'20159,012,427'Pharmaceutical combinations comprising a thionucleotide analog'20158,877,731'Azido nucleosides and nucleotide analogs'20148,871,737'Substituted nucleotide analogs'20148,772,474'Cyclic nucleotide analogs'20148,236,779'Antiviral nucleosides'20128,158,779'Antiviral nucleosides'20128,119,636'Pyrrolopyrazine kinase inhibitors'20128,063,025'Nucleoside prodrugs and uses thereof'20118,008,298'Pyrrolopyrazine kinase inhibitors'20117,939,531'Pyrrolopyrazine kinase inhibitors'20117,935,681'Antiviral nucleosides'20117,723,391'Cyclopropyl aryl amide derivatives and uses thereof'20107,666,856'Antiviral nucleosides'20107,608,599'Antiviral phosphoramidates'20097,378,402'Anti-viral nucleosides'20087,186,840'Quinoline derivatives as anti-inflammatory agents'20077,105,666'Synthesis of purine derivatives'20067,071,177'P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents'20067,049,325'Quinoline derivatives as anti-inflammatory agents'20066,984,637'Cyclic amine derivatives-CCR-3 receptor antagonists'20066,977,265'Piperidine CCR-3 receptor antagonists'20056,906,073'Piperazine CCR-3 receptor antagonists'20056,900,336'8-aza-11-deoxy prostaglandin analogues'20056,849,657'2-pyrrolidone derivatives as prostanoid agonists'20056,846,810'Antiviral nucleoside derivatives'20056,770,650'Cyclic amine derivatives-CCR-3 receptor antagonists'20046,759,428'Indole nitriles'20046,747,053'Heteroaryl nitriles'20046,683,074'Cyclic amine derivatives-CCR-3 receptor antagonists'20046,433,005'Benzofuran and benzothiophene derivatives as anti-inflammatory agents'20026,339,087'Cyclic amine derivatives-CCR-3 receptor antagonists'20026,323,223'Cyclic amine derivatives- CCR-3 receptor antagonists'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2006Patents assigned to SYNTEX LLC (10)· patent assignee history
2001–2020Based in San Mateo, CA, US· patent location history
2004–2012Patents assigned to ROCHE PALO ALTO LLC (12)· patent assignee history
2011–2014Patents assigned to SMITH DAVID BERNARD (7)· patent assignee history
2014–2019Patents assigned to ALIOS BIOPHARMA INC (27)· patent assignee history
2019–2020Patents assigned to JANSSEN BIOPHARMA INC (7)· patent assignee history
2021Based in Augusta, GA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ALIOS BIOPHARMA INC272014–2019
ROCHE PALO ALTO LLC122004–2012
SYNTEX LLC102001–2006
JANSSEN BIOPHARMA INC72019–2020
SMITH DAVID BERNARDself72011–2014
Locations
LocationPatentsSpan
San Mateo, California, US632001–2020
Augusta, Georgia, US12021